91
Views
37
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

The Effectiveness and Safety of Oral Linezolid for the Primary and Secondary Treatment of Osteomyelitis

Pages 643-650 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Sally Ager & Kate Gould. (2012) Clinical update on linezolid in the treatment of Gram-positive bacterial infections. Infection and Drug Resistance 5, pages 87-102.
Read now
Javier Cobo & Jose Luis Del Pozo. (2011) Prosthetic joint infection: diagnosis and management. Expert Review of Anti-infective Therapy 9:9, pages 787-802.
Read now
A. Papadopoulos, D. Plachouras, E. Giannitsioti, G. Poulakou, H. Giamarellou & K. Kanellakopoulou. (2009) Efficacy and Tolerability of Linezolid in Chronic Osteomyelitis and Prosthetic Joint Infections: A Case-Control Study. Journal of Chemotherapy 21:2, pages 165-169.
Read now
Juan García-Lechuz & Emilio Bouza. (2009) Treatment recommendations and strategies for the management of bone and joint infections. Expert Opinion on Pharmacotherapy 10:1, pages 35-55.
Read now
O. Kandemir, V. Oztuna, M. Colak, A. Akdag & H. Camdeviren. (2008) Comparison of the Efficacy of Tigecycline and Teicoplanin in an Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis Model. Journal of Chemotherapy 20:1, pages 53-57.
Read now
Philippa C Matthews, Anthony R Berendt & Benjamin A Lipsky. (2007) Clinical management of diabetic foot infection: diagnostics, therapeutics and the future. Expert Review of Anti-infective Therapy 5:1, pages 117-127.
Read now

Articles from other publishers (31)

Anja R. Zelmer, Renjy Nelson, Katharina Richter & Gerald J. Atkins. (2022) Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis. Bone Research 10:1.
Crossref
Yan Qin, Yangxi Liu, Zhe Chen, Mingchen Cao, Yun Shen & Yanrong Ye. (2021) A risk factor‐based predictive model for linezolid‐induced anaemia: A 7‐year retrospective study. Journal of Clinical Pharmacy and Therapeutics 46:6, pages 1591-1599.
Crossref
Nicolás W Cortés-Penfield & Prathit A Kulkarni. (2019) The History of Antibiotic Treatment of Osteomyelitis. Open Forum Infectious Diseases 6:5.
Crossref
Jongtak Jung, Eunyoung Lee, Kyoung-Ho Song, Pyoeng Gyun Choe, Wan Beom Park, Ji Hwan Bang, Eu Suk Kim, Hong Bin Kim, Sang Won Park, Nam Joong Kim & Myoung-don Oh. (2018) Efficacy and Tolerability of Linezolid for Treatment of Infectious Spondylitis. The Korean Journal of Medicine 93:5, pages 464-472.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 407 414 .
B.-N. Kim, E. S. Kim & M.-D. Oh. (2013) Oral antibiotic treatment of staphylococcal bone and joint infections in adults. Journal of Antimicrobial Chemotherapy 69:2, pages 309-322.
Crossref
Ryan P. Moenster, Travis W. Linneman, William B. Call, Chad L. Kay, Theresa A. McEvoy & Jamie L. Sanders. (2013) The potential role of newer gram-positive antibiotics in the setting of osteomyelitis of adults. Journal of Clinical Pharmacy and Therapeutics 38:2, pages 89-96.
Crossref
Allison L. Mruk & Kenneth E. Record. (2012) Antimicrobial Options in the Treatment of Adult Staphylococcal Bone and Joint Infections in an Era of Drug Shortages. Orthopedics 35:5, pages 401-407.
Crossref
Baek-Nam Kim. (2011) Oral Agents for the Treatment of Orthopedic Infections Caused by Methicillin-resistant Staphylococci. Infection & Chemotherapy 43:4, pages 322.
Crossref
Michael PfallerBenjamin Howden. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition 895 919 .
L. Legout, M. Valette, H. Dezeque, S. Nguyen, X. Lemaire, C. Loiez, M. Caillaux, E. Beltrand, L. Dubreuil, Y. Yazdanpanah, H. Migaud & E. Senneville. (2010) Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia?. Journal of Antimicrobial Chemotherapy 65:10, pages 2224-2230.
Crossref
Hamid Zahedi. 2010. Cases on Health Outcomes and Clinical Data Mining. Cases on Health Outcomes and Clinical Data Mining 15 46 .
Roberto Manfredi & Sergio Sabbatani. (2010) Novel pharmaceutical molecules against emerging resistant gram-positive cocci. The Brazilian Journal of Infectious Diseases 14:1, pages 96-108.
Crossref
. 2010. Meyler's Side Effects of Antimicrobial Drugs. Meyler's Side Effects of Antimicrobial Drugs 1 443 .
E. Bouza. (2009) New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection 15, pages 44-52.
Crossref
S. Esposito, S. Leone, M. Bassetti, S. Borrè, F. Leoncini, E. Meani, M. Venditti & F. Mazzotta. (2009) Italian Guidelines for the Diagnosis and Infectious Disease Management of Osteomyelitis and Prosthetic Joint Infections in Adults. Infection 37:6, pages 478-496.
Crossref
Diamantis P. Kofteridis, Polychronis Malliotakis, Sofia Maraki, Maria Christofaki & George Samonis. (2009) Impact of prolonged treatment with linezolid on the human gut flora. International Journal of Infectious Diseases 13:5, pages e313-e315.
Crossref
Roy F. Chemaly, Santosh S. Hanmod, Ying Jiang, Dhanesh B. Rathod, Victor Mulanovich, Javier A. Adachi, Kenneth V. Rolston, Issam I. Raad & Ray Y. Hachem. (2009) Tigecycline Use in Cancer Patients With Serious Infections. Medicine 88:4, pages 211-220.
Crossref
Elizabeth D. Hermsen, Sara S. Shull, Isaac F. Mitropoulos, Susan E. Puumala & Mark E. Rupp. (2009) Prospective Evaluation of Clinical and Economic Outcomes Associated With Treatment of Serious Infections Due to Gram-Positive Cocci. Infectious Diseases in Clinical Practice 17:1, pages 17-21.
Crossref
É. Senneville, L. Legout, C. Loïez & H. Migaud. (2009) Prescripción de antibióticos en cirugía ortopédica. EMC - Técnicas Quirúrgicas - Ortopedia y Traumatología 1:1, pages 1-8.
Crossref
Javier Cobo. (2008) Papel de los grampositivos en las infecciones osteoarticulares. Enfermedades Infecciosas y Microbiología Clínica 26, pages 31-43.
Crossref
Natascia Corti & Alexander Imhof. 2008. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions 297 315 .
É. Senneville, L. Legout, C. Loïez & H. Migaud. (2008) Technique de prescription des antibiotiques en chirurgie orthopédique. EMC - Techniques chirurgicales - Orthopédie - Traumatologie 3:2, pages 1-7.
Crossref
J. R. Lentino, M. Narita & V. L. Yu. (2007) New antimicrobial agents as therapy for resistant gram-positive cocci. European Journal of Clinical Microbiology & Infectious Diseases 27:1, pages 3-15.
Crossref
Chih-Jung Chen, Cheng-Hsun Chiu, Tzou-Yien Lin, Zhon-Liau Lee, Wen-E Yang & Yhu-Chering Huang. (2007) Experience With Linezolid Therapy in Children With Osteoarticular Infections. Pediatric Infectious Disease Journal 26:11, pages 985-988.
Crossref
Nalini Rao & Cindy W. Hamilton. (2007) Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. Diagnostic Microbiology and Infectious Disease 59:2, pages 173-179.
Crossref
J. H. S. You, G. C. H. Lee, R. K. H. So, K. W. Cheung & M. Hui. (2007) Linezolid versus Vancomycin for Prosthetic Joint Infections: a Cost Analysis. Infection 35:4, pages 265-270.
Crossref
María José Menéndez Calderón, Juan Gorostidi, Evaristo Lombardero Rico & Patricia Bueno. (2007) Anemia y neuropatía periférica secundarias a linezolid. Medicina Clínica 129:1, pages 36-37.
Crossref
Matthew E. Falagas, Ilias I. Siempos, Panayiotis J. Papagelopoulos & Konstantinos Z. Vardakas. (2007) Linezolid for the treatment of adults with bone and joint infections. International Journal of Antimicrobial Agents 29:3, pages 233-239.
Crossref
Eric Senneville, Laurence Legout, Michel Valette, Yazdan Yazdanpanah, Eric Beltrand, Michèle Caillaux, Henri Migaud & Yves Mouton. (2006) Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: A retrospective study. Clinical Therapeutics 28:8, pages 1155-1163.
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.